Am J Transplant, Volume 21, Suppl 3 Archives - Page 70 of 139 - ATC Abstracts

2021 American Transplant Congress
True Living Donation Experiences: A Thematic Analysis of Storytelling from Kidney Living Donors
E. Ho¹, E. H. Wood², R. Pines³, L. A. Davis⁴, S. M. Advani⁵, A. D. Waterman²
¹Terasaki Institute, Los Angeles, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Cottage Hospital, Santa Barbara, CA, ⁴DeSales University, Center Valley, PA, ⁵National Human Genome Research Institute (NIH), Bethesda, MD
*Purpose: Personal experiences of living donors (LDs) or recipients (Rs) can motivate more individuals to pursue living donor kidney transplant. After building a library of…
2021 American Transplant Congress
Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes
O. Lee¹, K. Lee¹, J. Park¹, J. Lee², G. Kwon³, K. Kim⁴
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Medicine, Samsung Medical Center, Seoul, Korea, Republic of, ³Pathology, Samsung Medical Center, Seoul, Korea, Republic of, ⁴Biostatistics, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Subclinical rejection (SCR) is associated with chronic allograft nephropathy, which is the most common cause of allograft failure in kidney transplantation (KT). Therefore, early…
2021 American Transplant Congress
Renal Transplant is Safe in Septuagenarians
P. Serrano Rodriguez, J. Vonderau, K. Szempruch, C. S. Desai
Abdominal Transplant Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: With increasing life expectancy, there has been increase in transplant rates amongst elderly recipients who often have more comorbidities than younger recipient. The aim…
2021 American Transplant Congress
The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight
S. Mandala¹, N. Khodieva², A. Bigness¹, S. Mohamed², H. Mohammed¹, K. Robichaux², A. Brueckner³, R. Baliga⁴, J. Buggs⁵, A. Kumar¹, L. Bowman³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Pharmacy, Tampa General Hospital, Tampa, FL, ⁴Nephrology, Florida Kidney Physicians, Tampa, FL, ⁵Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Alemtuzumab, a potent anti-CD52 monoclonal antibody is used for induction immunosuppression post-renal transplantation as a fixed 30mg dose regardless of the patient’s weight. The…
2021 American Transplant Congress
Belatacept Utilization During the Covid-19 Pandemic in the United States
M. MacConmara, A. Shubin, D. Wojciechowski, L. de Gregorio, J. Shah, P. Vagefi, C. S. Hwang
Department of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: With the onset of the COVID-19 pandemic, many people in the United States were urged to stay at home. Kidney transplantation continued during this…
2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
M. G. Naik, K. Sakurayama, K. Budde, F. Halleck
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…
2021 American Transplant Congress
Which Living Kidney Donors Arrive to the Donation Process Informed About Surgery?
L. Malinzak, A. Segal, R. Prashar, M. Jesse
Henry Ford Hospital, Detroit, MI
*Purpose: To evaluate perceived knowledge about surgery in potential living kidney donors embarking on the donation process.*Methods: Potential living kidney donors were surveyed about their…
2021 American Transplant Congress
Robotic versus Open Mini-incision Living Donor Nephrectomy: Single Center Experience
S. Lee¹, S. Z. Wang², A. Khan¹, A. Sharma¹, D. Kumar³, L. Kamal³, A. Cotterell¹, V. Kumaran¹, D. Bruno¹, M. Levy¹, C. Bhati¹
¹Transplant Surgery, Virginia Commonwealth University hospital, Richmond, VA, ²Medical School, Virginia Commonwealth University, Richmond, VA, ³Transplant Nephrology, Virginia Commonwealth University hospital, Richmond, VA
*Purpose: A minimally invasive approach is the gold standard for living donor nephrectomy (LDN). While robotic surgery is commonly used for native nephrectomies and urological…
2021 American Transplant Congress
The Use of Donor Derived Cell Free DNA in Children to Monitor Therapy of Kidney Rejection
A. Al-Uzri, M. Wright, K. Clark, R. Jenkins
Oregon Health & Science Univ, Portland, OR
*Purpose: Elevated donor-derived cell-free DNA (dd-cfDNA) in the presence of HLA donor-specific antibodies (DSA) are shown to correlate with acute antibody-mediated rejection (AMR) in adult…
2021 American Transplant Congress
To Whom do Pediatric Donor Organs Go?
J. Smith¹, M. Skeans², R. Engen³, S. Bartosh⁴
¹Seattle Children's Hospital, Seattle, WA, ²SRTR, Minneapolis, MN, ³Lurie Children's Hospital, Chicago, IL, ⁴Univ of Wisconsin, Madison, WI
*Purpose: Pediatric priority in organ allocation is mandated by the Final Rule, but prioritization varies by organ, sometimes informed by size-matching needs. Heart (Policy 6.6.E)…